Staats Lab Awarded NIH SBIR Grant

The Staats Lab was recently awarded an NIH SBIR grant titled “VesiVax® Peanut Allergy Immunotherapy”.  Studies will be performed to determine if liposome formulations of peanut extract combined with vaccine adjuvants can be used as an immunotherapeutic to treat peanut allergy. This grant represents a collaborative effort between the Staats lab and Molecular Express, a biotechnology company developing liposomal adjuvant formulations.

(Photo: Brandi Johnson-Weaver, PhD,  and Herman Staats, PhD)